17-39462052-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_016507.4(CDK12):c.-20T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00021 in 1,600,580 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0011 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
CDK12
NM_016507.4 5_prime_UTR
NM_016507.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.50
Genes affected
CDK12 (HGNC:24224): (cyclin dependent kinase 12) Enables RNA polymerase II CTD heptapeptide repeat kinase activity and cyclin binding activity. Involved in phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; and regulation of MAP kinase activity. Located in nuclear speck. Part of cyclin K-CDK12 complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 17-39462052-T-C is Benign according to our data. Variant chr17-39462052-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 1678977.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 167 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK12 | NM_016507.4 | c.-20T>C | 5_prime_UTR_variant | 1/14 | ENST00000447079.6 | NP_057591.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK12 | ENST00000447079.6 | c.-20T>C | 5_prime_UTR_variant | 1/14 | 1 | NM_016507.4 | ENSP00000398880 | P4 | ||
CDK12 | ENST00000430627.6 | c.-20T>C | 5_prime_UTR_variant | 1/14 | 1 | ENSP00000407720 | A1 | |||
CDK12 | ENST00000584632.5 | c.-20T>C | 5_prime_UTR_variant | 1/13 | 5 | ENSP00000464641 | ||||
CDK12 | ENST00000559663.2 | c.-20T>C | 5_prime_UTR_variant, NMD_transcript_variant | 1/21 | 5 | ENSP00000453329 |
Frequencies
GnomAD3 genomes AF: 0.00109 AC: 166AN: 152094Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
166
AN:
152094
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000283 AC: 70AN: 247324Hom.: 0 AF XY: 0.000224 AC XY: 30AN XY: 134092
GnomAD3 exomes
AF:
AC:
70
AN:
247324
Hom.:
AF XY:
AC XY:
30
AN XY:
134092
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000117 AC: 169AN: 1448368Hom.: 0 Cov.: 31 AF XY: 0.000106 AC XY: 76AN XY: 719134
GnomAD4 exome
AF:
AC:
169
AN:
1448368
Hom.:
Cov.:
31
AF XY:
AC XY:
76
AN XY:
719134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00110 AC: 167AN: 152212Hom.: 1 Cov.: 32 AF XY: 0.00108 AC XY: 80AN XY: 74412
GnomAD4 genome
AF:
AC:
167
AN:
152212
Hom.:
Cov.:
32
AF XY:
AC XY:
80
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary breast ovarian cancer syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | National Health Laboratory Service, Universitas Academic Hospital and University of the Free State | Apr 19, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at